erythrosine has been researched along with Osteosarcoma in 17 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteosarcoma is the most prevalent primary malignant bone tumor, but treatment is difficult and prognosis remains poor." | 5.43 | Shock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexate. ( Deng, P; Junger, WG; Qi, B; Sun, D; Wang, C; Wang, T; Xia, Y; Yao, J; Yu, T; Zhang, X, 2016) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "Osteosarcoma is the most prevalent primary malignant bone tumor, but treatment is difficult and prognosis remains poor." | 1.43 | Shock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexate. ( Deng, P; Junger, WG; Qi, B; Sun, D; Wang, C; Wang, T; Xia, Y; Yao, J; Yu, T; Zhang, X, 2016) |
| "The use of neo-adjuvant chemotherapy in treating osteosarcoma has improved patients' average 5 year survival rate from 20% to 70% in the past 30 years." | 1.36 | Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. ( Amiji, MM; Choy, E; Duan, Z; Hornicek, FJ; Iyer, AK; Mankin, H; Milane, L; Ryu, K; Susa, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, B | 1 |
| Yu, T | 1 |
| Wang, C | 1 |
| Wang, T | 1 |
| Yao, J | 1 |
| Zhang, X | 1 |
| Deng, P | 1 |
| Xia, Y | 1 |
| Junger, WG | 1 |
| Sun, D | 1 |
| Susa, M | 1 |
| Iyer, AK | 1 |
| Ryu, K | 1 |
| Choy, E | 1 |
| Hornicek, FJ | 1 |
| Mankin, H | 1 |
| Milane, L | 1 |
| Amiji, MM | 1 |
| Duan, Z | 1 |
| Ogawa, Y | 1 |
| Takahashi, T | 1 |
| Kobayashi, T | 1 |
| Kariya, S | 1 |
| Nishioka, A | 1 |
| Mizobuchi, H | 1 |
| Noguchi, M | 1 |
| Hamasato, S | 1 |
| Tani, T | 1 |
| Seguchi, H | 1 |
| Yoshida, S | 1 |
| Sonobe, H | 1 |
| Tian, M | 1 |
| Wu, XL | 1 |
| Zhang, B | 1 |
| Li, JL | 1 |
| Shi, Z | 1 |
| Zahr, KA | 1 |
| Sherman, JE | 1 |
| Chaglassian, T | 1 |
| Lane, JM | 1 |
| Hunter, A | 1 |
| Archer, CW | 1 |
| Walker, PS | 1 |
| Blunn, GW | 1 |
| Minamikawa, T | 1 |
| Williams, DA | 1 |
| Bowser, DN | 1 |
| Nagley, P | 1 |
| Ahmad, M | 1 |
| McCarthy, MB | 1 |
| Gronowicz, G | 1 |
| Molenaar, C | 1 |
| Teuben, JM | 1 |
| Heetebrij, RJ | 1 |
| Tanke, HJ | 1 |
| Reedijk, J | 1 |
| Heath, DJ | 1 |
| Downes, S | 1 |
| Verderio, E | 1 |
| Griffin, M | 1 |
| Neri, S | 1 |
| Mariani, E | 1 |
| Meneghetti, A | 1 |
| Cattini, L | 1 |
| Facchini, A | 1 |
| Porcelli, AM | 1 |
| Scotlandi, K | 1 |
| Strammiello, R | 1 |
| Gislimberti, G | 1 |
| Baldini, N | 1 |
| Rugolo, M | 1 |
| Ganz, MB | 1 |
| Pachter, JA | 1 |
| Barber, DL | 1 |
| Garnett, MC | 1 |
| Baldwin, RW | 1 |
| Bell, RS | 1 |
| Bourret, LA | 1 |
| Bell, DF | 1 |
| Gebhardt, MC | 1 |
| Rosenberg, A | 1 |
| Berrey, HB | 1 |
| Treadwell, BV | 1 |
| Tomford, WW | 1 |
| Mankin, HJ | 1 |
| Marsh, B | 1 |
| Flynn, L | 1 |
| Enneking, W | 1 |
1 review available for erythrosine and Osteosarcoma
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
1 trial available for erythrosine and Osteosarcoma
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
16 other studies available for erythrosine and Osteosarcoma
| Article | Year |
|---|---|
Shock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexate.
Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cell Prol | 2016 |
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2010 |
Mechanism of apoptotic resistance of human osteosarcoma cell line, HS-Os-1, against irradiation.
Topics: Annexin A5; Apoptosis; Cell Line, Tumor; Child; DNA Damage; DNA, Mitochondrial; Female; Fluoresceins | 2003 |
Synthesis of chlorinated fluoresceins for labeling proteins.
Topics: Bone Neoplasms; Chlorine; DNA Primers; Fluoresceins; Fluorescent Dyes; Humans; Molecular Structure; | 2008 |
Prediction of skin viability following en bloc resection for osteogenic sarcoma with fluorescein.
Topics: Bone Neoplasms; Fluoresceins; Humans; Osteosarcoma; Prognosis; Skin; Skin Transplantation; Surgical | 1983 |
Attachment and proliferation of osteoblasts and fibroblasts on biomaterials for orthopaedic use.
Topics: Actins; Alloys; Analysis of Variance; Animals; Benzophenones; Biocompatible Materials; Bone Neoplasm | 1995 |
Mitochondrial permeability transition and swelling can occur reversibly without inducing cell death in intact human cells.
Topics: Aldehydes; Apoptosis; Benzimidazoles; Carbocyanines; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell | 1999 |
An in vitro model for mineralization of human osteoblast-like cells on implant materials.
Topics: Alloys; Biocompatible Materials; Blotting, Northern; Calcification, Physiologic; Calcium; Cell Adhes | 1999 |
New insights in the cellular processing of platinum antitumor compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy.
Topics: Antineoplastic Agents; Bone Neoplasms; Cisplatin; Dinitrophenols; Fluoresceins; Fluorescent Dyes; Go | 2000 |
Characterization of tissue transglutaminase in human osteoblast-like cells.
Topics: Blotting, Western; Cadaverine; Cell Adhesion; Cell Membrane; Cells, Cultured; Extracellular Space; F | 2001 |
Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants.
Topics: Cell Survival; Chromium Radioisotopes; Cytotoxicity Tests, Immunologic; Fluoresceins; Fluorescent Dy | 2001 |
Intracellular pH regulation in U-2 OS human osteosarcoma cells transfected with P-glycoprotein.
Topics: Amiloride; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buffers; Chloride-Bicarbonate An | 2002 |
Multiple receptors coupled to adenylate cyclase regulate Na-H exchange independent of cAMP.
Topics: Adenylyl Cyclases; Amiloride; Animals; Astrocytoma; Carrier Proteins; Cricetinae; Epinephrine; Fluor | 1990 |
Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugates.
Topics: Antibodies, Monoclonal; Antigens, Surface; Cell Line; Endocytosis; Flow Cytometry; Fluorescein-5-iso | 1986 |
Evaluation of fluorescein diacetate for flow cytometric determination of cell viability in orthopaedic research.
Topics: Animals; Cartilage, Articular; Cell Survival; Doxorubicin; Evaluation Studies as Topic; Flow Cytomet | 1988 |
Immunologic aspects of osteosarcoma and their application to therapy. A preliminary report.
Topics: Adolescent; Adult; Animals; Antigens, Neoplasm; Blood Proteins; Bone Neoplasms; Child; Child, Presch | 1972 |